<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">OTD</journal-id><journal-title-group><journal-title>Oncology Treatment Discovery</journal-title></journal-title-group><issn>3083-4996</issn><eissn>2981-8079</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/otd.v4i2.15409</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>Clinical Diagnosis, Treatment and Prevention Strategies of HIV/AIDS-related Tumors</title><url>https://artdesignp.com/journal/OTD/4/2/10.26689/otd.v4i2.15409</url><author>GuoDong,ZhangYaxian</author><pub-date pub-type="publication-year"><year>2026</year></pub-date><volume>4</volume><issue>2</issue><history><date date-type="pub"><published-time>2026-06-30</published-time></date></history><abstract>HIV/AIDS-related tumors represent a significant challenge in the global public health arena. This article systematically elaborates on the clinical characteristics, diagnosis and treatment strategies, as well as prevention and control measures of HIV/AIDS-related tumors. The HIV virus causes immune deficiency by attacking CD4+ T lymphocytes, significantly increasing the risk of tumor development. Common types include Kaposi’s sarcoma, non-Hodgkin’s lymphoma, and invasive cervical cancer. Clinical diagnosis and treatment need to comprehensively consider the treatment of the tumor itself and immune reconstitution, adopting a combination of surgery, radiotherapy, chemotherapy, targeted therapy, and highly active antiretroviral therapy. In terms of prevention and control, the focus should be on primary prevention, including HIV screening, early diagnosis and treatment, and regular tumor screening, to reduce the disease burden and improve patient prognosis.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>UNAIDS, 2025, Global AIDS Update 2025. Global AIDS Update, UNAIDS, Geneva.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>AIDS Study Group, Society of Infectious Diseases, Chinese Medical Association, 2025, Guidelines for the Diagnosis and Treatment of AIDS in China (2025 Edition), Beijing.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Chen J, Cai S, Lu A, 2025, Expert Consensus on the Diagnosis and Treatment of AIDS-defining Tumors. Chinese Journal of AIDS &amp; STD, 31(6): 579–598.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Wang CY, Liu J, Liang XP, et al., 2022, Clinical Characteristics and Prognostic Features of 63 HIV-associated Diffuse Large B-cell Lymphoma. Frontiers in Oncology, 12: 907206.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Cui Y, Deng Y, Wu J, et al., 2025, Clinicopathological Analysis of 26 Cases of AIDS-related Kaposi’s Sarcoma and Review of Relevant Literature. Journal of Rare and Uncommon Diseases, 32(10): 3–5.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>Chen Y, 2025, Estimation of the Global Burden of Non-Hodgkin’s Lymphoma Attributable to HIV Infection, thesis, Southwest Medical University.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Luo L, Jiang Q, Hu X, et al., 2024, Research Progress on AIDS Complicated with Malignant Tumors. Chinese Journal of Nosocomiology, 34(17): 2715–2720.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Reid E, Suneja G, Ambinder RF, et al., 2019, AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 17(2): 171–189.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Pang L, Xu L, Liu L, 2026, Survival Analysis of HIV/AIDS Cases Receiving Antiviral Treatment in Weinan City from 2004 to 2023. Preventive Medicine, 38(2): 176–180.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Wu Y, Gao Q, 2025, Analysis of Viral Load and CD4+ T Lymphocyte Test Results in 422 HIV Patients with Low Viremia. Journal of Applied Preventive Medicine, 31(6): 587–590.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Yin X, Yang S, 2025, Preventive Effects of Different Supportive Treatment Regimens on Myelosuppression after Chemotherapy in Patients with Acquired Immunodeficiency Syndrome Complicated with Malignant Tumors. Journal of Cancer Research and Clinical Oncology, 38(6): 882–885.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Tan Y, 2025, Exploration of a Multidisciplinary Collaborative Nursing Model for Patients with AIDS Complicated with Tumors. Disease Prevention and Control, 1(6): 61–64.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Ding G, Qin Q, Fan M, et al., 2025, Research on Strategies and Effect Evaluation of Public Health Management in AIDS Prevention and Control. Disease Prevention and Control, 1(5): 41–44.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Huang C, An X, Yang T, et al., 2026, Meta-analysis of Timeliness and Influencing Factors of Antiviral Treatment in Chinese HIV/AIDS Patients from 2016 to 2024. Journal of Preventive Medicine Information, 1–12.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
